[en] Aim: Cardiotrophin-1 (CT-1) is upregulated by hypoxemia and hemodynamic overload and is characterized by potent hypertrophic and protective properties on cardiac cells. This study aimed to investigate whether CT-1 is differentially induced in the myocardium of infants with congenital cardiac defects depending on hypoxemia. Methods & results: Infants with Tetralogy of Fallot (n = 8) or with large nonrestrictive ventricular septal defect (n = 8) undergoing corrective surgery were investigated. Expression of CT-1 was assessed at mRNA and protein levels in the right atrial and ventricular myocardium. The activation of the STAT-3 and VEGF were measured. Degradation of cardiac troponin-I served as a marker of myocardial damage. CT-1 was detected in all patients with levels negatively correlating to the arterial oxygen saturation. Higher CT-1 expression in Tetralogy of Fallot patients was associated with activation of the JAK/STAT pathway and higher cardiac troponin-I degradation. Conclusion: CT-1 may mediate myocardial hypertrophy and dysfunction in infants with congenital cardiac defects, particularly in those with hypoxemia.
scite shows how a scientific paper has been cited by providing the context of the citation, a classification describing whether it supports, mentions, or contrasts the cited claim, and a label indicating in which section the citation was made.
Bibliography
Sheng Z, Knowlton K, Chen J, Hoshijima M, Brown JH, Chien KR. Cardiotrophin 1 (CT 1) inhibition of cardiac myocyte apoptosis via a mitogen-activated protein kinase-dependent pathway. Divergence from downstream CT 1 signals for myocardial cell hypertrophy. J. Biol. Chem. 272(9), 5783-5791 (1997
Potter DD, Araoz PA, Ng Ll et al. Cardiotropin 1 and myocardial strain change heterogeneously in cardiomyopathy. J. Surg. Res. 141(2), 277-283 (2007
Calabro P, Limongelli G, Riegler L et al. Novel insights into the role of cardiotrophin 1 in cardiovascular diseases. J. Mol. Cell Cardiol. 46(2), 142-148 (2009
Latchman DS. Cardiotrophin 1: A novel cytokine and its effects in the heart and other tissues. Pharmacol. Ther. 85(1), 29-37 (2000
Ichiki T, Jougasaki M, Setoguchi M et al. Cardiotrophin 1 stimulates intercellular adhesion molecule 1 and monocyte chemoattractant protein 1 in human aortic endothelial cells. Am. J. Physiol. Heart Circ. Physiol. 294(2), H750-H763 (2008
Lu Y, Zhou J, Xu C et al. JAK/STAT and PI3K/AKT pathways form a mutual transactivation loop and afford resistance to oxidative stress-induced apoptosis in cardiomyocytes. Cell. Physiol. Biochem. 21(4), 305-314 (2008
Gonzalez A, Ravassa S, Loperena I et al. Association of depressed cardiac gp130-mediated antiapoptotic pathways with stimulated cardiomyocyte apoptosis in hypertensive patients with heart failure. J. Hypertens. 25(10), 2148-2157 (2007
Malavazos AE, Ermetici F, Morricone L et al. Association of increased plasma cardiotrophin 1 with left ventricular mass indexes in normotensive morbid obesity. Hypertension 51(2), e8-e9; author reply e10 (2008
Talwar S, Downie PF, Squire IB, Barnett DB, Davies JD, Ng LL. An immunoluminometric assay for cardiotrophin 1: A newly identified cytokine is present in normal human plasma and is increased in heart failure. Biochem. Biophys. Res. Commun. 261(3), 567-571 (1999
Talwar S, Squire IB, Downie PF, O'Brien RJ, Davies JE, Ng LL. Elevated circulating cardiotrophin 1 in heart failure: Relationship with parameters of left ventricular systolic dysfunction. Clin. Sci. (Lond.) 99(1), 83-88 (2000
Ng LL, O'Brien RJ, Demme B, Jennings S. Non-competitive immunochemiluminometric assay for cardiotrophin 1 detects elevated plasma levels in human heart failure. Clin. Sci. (Lond.) 102(4), 411-416 (2002
Talwar S, Squire IB, Davies JE, Ng LL. The effect of valvular regurgitation on plasma cardiotrophin 1 in patients with normal left ventricular systolic function. Eur. J. Heart Fail. 2(4), 387-391 (2000
Zolk O, Engmann S, Munzel F, Krajcik R. Chronic cardiotrophin 1 stimulation impairs contractile function in reconstituted heart tissue. Am. J. Physiol. Endocrinol. Metab. 288(6), e1214-e1221 (2005
Asai S, Saito Y, Kuwahara K et al. The heart is a source of circulating cardiotrophin 1 in humans. Biochem. Biophys. Res. Commun. 279(2), 320-323 (2000
Hishinuma S, Funamoto M, Fujio Y, Kunisada K, Yamauchi-Takihara K. Hypoxic stress induces cardiotrophin 1 expression in cardiac myocytes. Biochem. Biophys. Res. Commun. 264(2), 436-440 (1999
Pan J, Fukuda K, Saito M et al. Mechanical stretch activates the JAK/STAT pathway in rat cardiomyocytes. Circ. Res. 84(10), 1127-1136 (1999
Qing M, Nimmesgern A, Heinrich PC et al. Intrahepatic synthesis of tumor necrosis factor-alpha related to cardiac surgery is inhibited by interleukin 10 via the Janus kinase (JAK)/signal transducers and activator of transcription (STAT) pathway. Crit. Care Med. 31(12), 2769-2775 (2003
Freed DH, Moon MC, Borowiec AM, Jones SC, Zahradka P, Dixon IM. Cardiotrophin 1: Expression in experimental myocardial infarction and potential role in post-MI wound healing. Mol. Cell Biochem. 254(1-2), 247-256 (2003
Aoyama T, Takimoto Y, Pennica D et al. Augmented expression of cardiotrophin 1 and its receptor component, gp130, in both left and right ventricles after myocardial infarction in the rat. J. Mol. Cell. Cardiol. 32(10), 1821-1830 (2000
Qing M, Schumacher K, Heise R et al. Intramyocardial synthesis of pro-and anti-inflammatory cytokines in infants with congenital cardiac defects. J. Am. Coll. Cardiol. 41(12), 2266-2274 (2003
Qing M, Gorlach A, Schumacher K et al. The hypoxia-inducible factor HIF 1 promotes intramyocardial expression of VEGF in infants with congenital cardiac defects. Basic Res. Cardiol. 102(3), 224-232 (2007
Kunisada K, Tone E, Fujio Y, Matsui H, Yamauchi-Takihara K, Kishimoto T. Activation of gp130 transduces hypertrophic signals via STAT3 in cardiac myocytes. Circulation 98(4), 346-352 (1998
Lee KS, Park JH, Lee S, Lim HJ, Choi HE, Park HY. HB-EGF induces delayed STAT3 activation via NF kappaB mediated IL 6 secretion in vascular smooth muscle cell. Biochim. Biophys. Acta 1773(11), 1637-1644 (2007
Kunisada K, Negoro S, Tone E et al. Signal transducer and activator of transcription 3 in the heart transduces not only a hypertrophic signal but a protective signal against doxorubicin-induced cardiomyopathy. Proc. Natl Acad. Sci. USA 97(1), 315-319 (2000
Funamoto M, Fujio Y, Kunisada K et al. Signal transducer and activator of transcription 3 is required for glycoprotein 130-mediated induction of vascular endothelial growth factor in cardiac myocytes. J. Biol. Chem. 275(14), 10561-10566 (2000
Palmer BS, Klawitter PF, Reiser PJ, Angelos MG. Degradation of rat cardiac troponin I during ischemia independent of reperfusion. Am. J. Physiol. Heart Circ. Physiol. 287(3), H1269-H1275 (2004
McDonough JL, Arrell DK, Van Eyk JE. Troponin I degradation and covalent complex formation accompanies myocardial ischemia/reperfusion injury. Circ. Res. 84(1), 9-20 (1999
Wollert KC, Taga T, Saito M et al. Cardiotrophin 1 activates a distinct form of cardiac muscle cell hypertrophy. Assembly of sarcomeric units in series via gp130/leukemia inhibitory factor receptor-dependent pathways. J. Biol. Chem. 271(16), 9535-9545 (1996
Freed DH, Borowiec AM, Angelovska T, Dixon IM. Induction of protein synthesis in cardiac fibroblasts by cardiotrophin 1: Integration of multiple signaling pathways. Cardiovasc. Res. 60(2), 365-375 (2003
Freed DH, Cunnington RH, Dangerfield AL, Sutton JS, Dixon IM. Emerging evidence for the role of cardiotrophin 1 in cardiac repair in the infarcted heart. Cardiovasc. Res. 65(4), 782-792 (2005
Similar publications
Sorry the service is unavailable at the moment. Please try again later.
This website uses cookies to improve user experience. Read more
Save & Close
Accept all
Decline all
Show detailsHide details
Cookie declaration
About cookies
Strictly necessary
Performance
Strictly necessary cookies allow core website functionality such as user login and account management. The website cannot be used properly without strictly necessary cookies.
This cookie is used by Cookie-Script.com service to remember visitor cookie consent preferences. It is necessary for Cookie-Script.com cookie banner to work properly.
Performance cookies are used to see how visitors use the website, eg. analytics cookies. Those cookies cannot be used to directly identify a certain visitor.
Used to store the attribution information, the referrer initially used to visit the website
Cookies are small text files that are placed on your computer by websites that you visit. Websites use cookies to help users navigate efficiently and perform certain functions. Cookies that are required for the website to operate properly are allowed to be set without your permission. All other cookies need to be approved before they can be set in the browser.
You can change your consent to cookie usage at any time on our Privacy Policy page.
